EpiGentek CRISPR/Cas9 SaCas9 Monoclonal Antibody [6H4]

Monday, 11 December, 2017 | Supplied by: Sapphire Bioscience


EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus Cas9 (SaCas9) and enables easy and specific monitoring of gene editing processes.

The CRISPR/Cas9 system allows for sequence-specific cleavage of a targeted genomic locus by delivering the RNA-guided Cas9 nuclease and appropriate guide RNAs into a cell. In addition, the protospacer adjacent motif (PAM) sequence immediately following the specificity sequence is necessary for successful binding of the Cas9 nuclease.

It is important to monitor the level of Cas9 editing protein or track the Cas9 editing protein in transfected cells, as it will show transfection efficiency and optimise the editing process in the total cell population. SaCas9-mediated genome editing has been reported in human cells and Arabidopsis. Because SaCas9 (1053 a.a.) is smaller than Streptococcus pyogenes Cas9 (SpCas9) (1368 a.a.), SaCas9 could have advantages for delivering and expressing Cas9 protein, especially using virus vectors.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Amsbio BioPORTER Protein Delivery Reagent

The BioPORTER Protein Delivery Reagent from Amsbio is a specialised, lipid-based reagent designed...

Amsbio StemFit Basic04CT stem cell medium

StemFit Basic04CT from Amsbio is an animal-origin-free, defined, ready-to-use medium designed to...

Takara Bio Europe Cellartis MSC EV Wonder GMP-grade medium

Takara Bio Europe has introduced a Good Manufacturing Practice (GMP)-grade version of Cellartis...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd